Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey.

Guaraldi, Federica; Montalti, Marco; Di Valerio, Zeno; Mannucci, Edoardo; Nreu, Besmir; Monami, Matteo; Gori, Davide

Guaraldi, Federica; Montalti, Marco; Di Valerio, Zeno; Mannucci, Edoardo; Nreu, Besmir; Monami, Matteo; Gori, Davide.

Afiliação

Guaraldi F; Pituitary Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
Montalti M; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.
Di Valerio Z; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.
Mannucci E; Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.
Nreu B; Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.
Monami M; Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.
Gori D; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.

Vaccines (Basel) ; 9(5)2021 May 04.

Article em En | MEDLINE | ID: mdl-34064486

Palavras-chave

COVID-19; SARS-CoV-2 vaccine; type 2 diabetes; vaccine hesitancy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google